Sino Biopharmaceutical Limited SBHMY
14.40 USD +2.36 (+19.60%)
Nov 10, 2026, 3:43 PM EST
14.23 Day range 14.40
11.27 52-week range 19.45
- YTD
- -20.97%
- 1 year
- -25.93%
- Market cap
- 12.80B
- EPS (ttm)
- 0.38
- P/E ratio
- 37.89
- YTD return
- -20.97%
- 1-year return
- -25.93%
- Volume
- 200
- Avg volume
- 756
- Open
- 14.23
- Previous close
- 12.04
- Day's range
- 14.23 – 14.40
- 52-week range
- 11.27 – 19.45
5D +2.58 (+21.43%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 15, 2025 | Jun 30, 2025 | — | 0.2621 | — | — |
| Mar 26, 2025 | Dec 31, 2024 | — | 0.00182 | — | — |
| Mar 20, 2025 | Sep 30, 2024 | — | 0.00189 | — | — |
| Aug 13, 2024 | Jun 30, 2024 | — | 0.01128 | — | — |
News
Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs 
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal 
Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion 
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln 
Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea 
Week In Review: JD Health Raises $3.5 Billion In Hong Kong IPO, Climbs 56% On First Day 
Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on SBHMY — it syncs with the Stock Master app.